All Type of News
Dong-A ST paying careful attention on the Chinese ABS due to the Korea-China FTA
As the actual settlement of the Korea-China FTA (Free Trade Agreement) has been made last November, domestic pharmaceutical companies are actively exploring and responding to the impact.
In particular, Dong-A ST usin...
A company has been approved to manufacture and sell the new drug, Acelex Cap, for the first time ever without any manufacturing facility
The Ministry of Food and Drug Safety (Minister Seung Jung) announced on the 5th to approve manufacturing and sales of the 22nd domestically developed new drug ‘Acelex Cap’ of CrystalGenomics.
‘Acelex Cap’, having ‘Po...
It is definite that CEO Han-gi Kim of Sinsin Pharm will be the new president of the Korea Pharmaceutical Traders Association
It is definite that the Korea Pharmaceutical Traders Association (KPTA)will newly appoint CEO Han-gi Kim (63 year old) of Sinsin Pharm.
CEO Kim has worked as a chief vice president of the KPTA for the past 3 years.
...
The Seoul National Labor Relations Commission dismissed the requisition of relief over the discharge of the chairman of the Bayer’s labor union
The Bayer’s labor-management legal battle has being favorable towards the management.
According to the industry concerned on the 6th, the Seoul National Labor Relations Commission (NLRC) has recently decided to dism...
The expected amount of annual claims of Erbitux is KRW 48 billion while the one of Revlimid is KRW 32 billion
It is known that the expected amounts of claims for the 4 anticancer drugs registered through the Risk Share Agreementare worth of KRW 90 billion.
Although they are anticancer drugs for a rare disease that has a smal...
The number of cancer patients went double for the past 5 years while the ratio was 3.5% of the total adults
It is known that the number of cancer patients has been up by double for the past 5 years; it showed a 3.5% ratio of the total adults.
According to the ‘Present Condition of the Number of Registered and Treated Patie...
Green Cross has targeted the Latin America with its blood fractionation product when its final goal is the U.S.Green Cross (CEO Eun-cheol Huh) announced on the 4th that the company won an order to supply Immunoglobulin IV Globulin S (IVIG-SN) worth of $ 5.72 million on the recent Brazili...
|
The pharmaceutical industry stated “Hard on generics while easy on OTC drugs”
The pharmaceutical industry suggested restricting thoughtless entries of generic products in the market. On the other hand, it requested easier approvals on OTC (Over The Counter) drugs.
At the 2015 Meeting of the Mi...
The distribution margin of GSK has been an issue again while the controversy is disadvantages of mid and small-sized companiesAs it is known that GSK will apply differential distribution margins on wholesale companies with the small monthly volume of businessby this April, the mid and small-sized whole...
|
.jpg)
How the tentative performance report shows the 10 listed pharmaceutical companies in 2014?
Although the pharmaceutical industry recorded a low growth rate in sales last year, it showed increasing performances in business profits and net profits.
According to the overall result of 10 listed pharmaceutical c...
